What is the latest status of the project “AGC Biologics Yokohama CDMO Expansion”?

The status recorded for “AGC Biologics Yokohama CDMO Expansion” is under construction.

What is the budget and commercial profile for the project “AGC Biologics Yokohama CDMO Expansion”?

Taiyo normalizes the budget of “AGC Biologics Yokohama CDMO Expansion” to USD 350000000.

Where can I verify the source and access all details for “AGC Biologics Yokohama CDMO Expansion”?

This Taiyo project page references Megaproject along with the original URL (https://megaproject.com/news/factory/agc-biologics-to-expand-cdmo-capabilities-in-japan-with-new-350m-yokohama-site). Taiyo standardizes official data into a consistent, searchable project profile.

AGC Biologics Yokohama CDMO Expansion

Under construction · Kanagawa · Last reported Apr 2026

Source: Megaproject

Project

Under Construction

AGC Biologics is building a new $350 million site in Yokohama, Japan, to expand its contract development and manufacturing organization (CDMO) capabilities. The facility will offer cell therapy, mammalian, and mRNA services, featuring large single-use bioreactor systems and supporting biologics manufacturing from early-phase development through commercial production.

Status: Under Construction
Sector: Manufacturing (Industrial), Commercial
Location: Yokohama, Kanagawa, Japan
Updated: 22 Jul 2026
Source: Megaproject

ConstructChat

Ask ConstructChat about AGC Biologics Yokohama CDMO Expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “AGC Biologics Yokohama CDMO Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Yokohama, Kanagawa, Japan. Taiyo aggregates data on it from Megaproject.

Participants

Not available for this record.

Status

Original status	under construction
Taiyo status	Under Construction
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	AGC Biologics is building a new $350 million site in Yokohama, Japan, to expand its contract development and manufacturing organization (CDMO) capabilities. The facility will offer cell therapy, mammalian, and mRNA services, featuring large single-use bioreactor systems and supporting biologics manufacturing from early-phase development through commercial production.
Original sector	factory
Budget

Location

Country	Japan
State	Kanagawa
City	Yokohama

Source

Source	Megaproject
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial), Commercial
Article published date	2026-04-18

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

AGC Biologics Yokohama CDMO Expansion

Ask ConstructChat about AGC Biologics Yokohama CDMO Expansion

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in Japan